BCM
TMO icon

Berbice Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Berbice Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$49.2K – 154
2026
Q1 		$49.2K Hold
100
– – 0.03% 83
2025
Q4 		$57.9K Hold
100
– – 0.03% 83
2025
Q3 		$48.5K Hold
100
– – 0.03% 93
2025
Q2 		$40.5K Hold
100
– – 0.03% 95
2025
Q1 		$49.8K Hold
100
– – 0.04% 82
2024
Q4 		$52K Buy
+100
New +$55K 0.04% 76

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Berbice Capital Management's TMO Position: Q2 2026 in Review

Berbice Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 100 shares — an estimated $49.2K sold.

Berbice Capital Management first reported a position in TMO in Q4 2024 and held it in 6 quarters. The position peaked at $57.9K in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Berbice Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Berbice Capital Management sold 100 Thermo Fisher Scientific shares in Q2 2026, an estimated $49.2K.
  • Berbice Capital Management first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 6 quarters.
  • Berbice Capital Management's Thermo Fisher Scientific position peaked at $57.9K in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Berbice Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.